Northwestern Mutual Wealth Management Co. acquired a new stake in Ventas, Inc. (NYSE:VTR – Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 43,220 shares of the real estate investment trust’s stock, valued at approximately $3,838,000.
A number of other hedge funds and other institutional investors have also modified their holdings of VTR. Evolve Private Wealth LLC bought a new stake in Ventas during the second quarter worth about $328,000. Varma Mutual Pension Insurance Co bought a new position in Ventas in the second quarter valued at approximately $13,921,000. Westpac Banking Corp acquired a new position in shares of Ventas during the 2nd quarter worth approximately $8,973,000. Korea Investment CORP bought a new stake in shares of Ventas during the 2nd quarter worth approximately $21,496,000. Finally, Ieq Capital LLC bought a new stake in shares of Ventas during the 2nd quarter worth approximately $13,913,000. Institutional investors and hedge funds own 94.18% of the company’s stock.
Ventas Stock Performance
VTR opened at $93.47 on Tuesday. Ventas, Inc. has a 12-month low of $66.38 and a 12-month high of $101.60. The stock has a market cap of $47.94 billion, a price-to-earnings ratio of 173.09, a PEG ratio of 2.15 and a beta of 0.69. The business has a 50 day moving average of $91.56 and a 200-day moving average of $87.26. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86.
Analysts Set New Price Targets
Several equities research analysts have recently commented on VTR shares. Royal Bank Of Canada increased their price objective on Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a report on Friday, August 14th. Weiss Ratings raised shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Tuesday, July 21st. JPMorgan Chase & Co. upped their price target on shares of Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Monday, May 11th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $100.00 price target on shares of Ventas in a research note on Tuesday, June 16th. Finally, Mizuho boosted their price objective on shares of Ventas from $98.00 to $104.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 22nd. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $98.00.
Read Our Latest Stock Analysis on VTR
Insider Transactions at Ventas
In related news, Director Michael J. Embler acquired 2,500 shares of Ventas stock in a transaction on Wednesday, June 3rd. The stock was purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the transaction, the director directly owned 19,202 shares in the company, valued at $1,513,309.62. This trade represents a 14.97% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.53% of the stock is owned by corporate insiders.
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
See Also
- Five stocks we like better than Ventas
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
